Matches in Nanopublications for { ?s ?p "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302524.RAbNhzA3DZB0zygD9uviiskioV0xXSnDAEI-kwu5PGyDI130_assertion description "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302524.RAbNhzA3DZB0zygD9uviiskioV0xXSnDAEI-kwu5PGyDI130_provenance.
- assertion description "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP535944.RAywM8iciDRVO8QGUyu3I8zO0IFSRUgQe5yJcMyoHWWO8130_assertion description "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535944.RAywM8iciDRVO8QGUyu3I8zO0IFSRUgQe5yJcMyoHWWO8130_provenance.
- assertion description "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP535941.RAOUxJUgSHFBj9OZGnrJxSVHPyPpWtD9PEddmtQV4dVME130_assertion description "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535941.RAOUxJUgSHFBj9OZGnrJxSVHPyPpWtD9PEddmtQV4dVME130_provenance.
- NP926279.RAn4uuzPhMLbmFaSH-CzCGvcLPgbuiWUEJ7V49PpPMLjg130_assertion description "[Together, these findings suggest that dysregulation of cyclin D1 sensitizes human myeloma cells to the actions of CDK inhibitors through mechanisms involving interference with p21(CIP1) expression, dephosphorylation of pocket proteins and inactivation of E2Fs culminating in S phase entry, as well as inactivation of NF-kappaB, leading to apoptosis rather than growth arrest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926279.RAn4uuzPhMLbmFaSH-CzCGvcLPgbuiWUEJ7V49PpPMLjg130_provenance.